Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Total Liabilities: 2010-2018

Historic Total Liabilities for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Jun 2018 value amounting to $60.0 million.

  • EyePoint Pharmaceuticals' Total Liabilities rose 47.70% to $62.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $62.0 million, marking a year-over-year increase of 47.70%. This contributed to the annual value of $60.0 million for FY2018, which is 1023.07% up from last year.
  • EyePoint Pharmaceuticals' Total Liabilities amounted to $60.0 million in FY2018, which was up 1,023.07% from $5.3 million recorded in FY2017.
  • In the past 5 years, EyePoint Pharmaceuticals' Total Liabilities registered a high of $60.0 million during FY2018, and its lowest value of $5.3 million during FY2017.
  • In the last 3 years, EyePoint Pharmaceuticals' Total Liabilities had a median value of $10.7 million in 2016 and averaged $25.4 million.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Total Liabilities slumped by 50.26% in 2017 and then skyrocketed by 1,023.07% in 2018.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Total Liabilities stood at $7.7 million in 2014, then rose by 16.16% to $9.0 million in 2015, then climbed by 19.32% to $10.7 million in 2016, then slumped by 50.26% to $5.3 million in 2017, then surged by 1,023.07% to $60.0 million in 2018.